Key messages
-
Kangaroo mother care (KMC) is a simple, low-cost approach that keeps babies warm, supports breathing and feeding, and allows parents to stay close to their newborn.
-
KMC likely reduces the risk of babies dying and getting a serious infection in hospital and it may increase breastfeeding.
-
Future research should investigate how best to deliver KMC in countries with different income levels and to infants of different gestational ages.
What is kangaroo mother care, and how does it work?
Kangaroo mother care (KMC) means holding a baby skin-to-skin against a parent's chest for several hours a day. This keeps the baby warm, supports stable breathing and feeding, helps the baby adjust to life outside the womb and may minimize exposure to infections. Beyond the medical benefits, it keeps parents close to their baby, builds confidence in caring for their newborn, and strengthens the parent–infant bond. The World Health Organization (WHO) recommends KMC for at least 8 hours a day.
What did we want to find out?
We wanted to find out whether KMC helps babies born early (before 37 weeks of pregnancy) or small (under 2500 g at birth) grow, stay healthy, and develop well. Specifically, we wanted to find out how it affects:
-
the risk of a baby dying for any reason;
-
a baby's' growth (measured by its weight during hospital stay)
-
breastfeeding;
-
how long a baby may need to stay in hospital;
-
risk of serious infection in hospital;
-
low body temperature.
What did we do?
We searched for studies that compared any form of KMC, or KMC that met the WHO recommendations, with standard hospital care. We then summarized the results of the studies and rated our confidence in the evidence, based on factors such as the size of the study (number of babies enrolled) and the methods used.
What did we find?
We included 49 studies with a total of 7724 babies born early or with a low birthweight.
Main results
Compared with standard hospital care, KMC:
-
likely reduces the risk of in-hospital death
-
may increase the likelihood that mothers are breastfeeding exclusively or in any form at the time babies go home from hospital or reach 40 to 41 weeks of age among infants born preterm
-
likely reduces the risk of serious infections picked up in hospital
-
may reduce the risk of low body temperature
We are very uncertain about the effect of KMC on:
-
the baby's weight when it goes home from hospital or reaches 40 to 41 weeks of age among infants born preterm
-
how long babies stay in hospital
What are the limitations of the evidence?
The way KMC was delivered varied considerably across studies, as did the definitions used for low body temperature and hospital-acquired infection. Breastfeeding was mostly reported by mothers themselves, which may have influenced results. The results of eight upcoming studies could change some of our results.
How up-to-date is this evidence?
The evidence is up-to-date to August 2025.
Read the full abstract
Background
Kangaroo mother care (KMC), originally defined as skin-to-skin contact between a mother and her newborn, frequent and exclusive or nearly exclusive breastfeeding, and early discharge from hospital, has been proposed as an alternative to conventional neonatal care for low birthweight (LBW) infants.
Objectives
To determine the benefits and harms of kangaroo mother care (KMC) in low birthweight infants as an alternative to conventional neonatal care before or after the initial period of stabilization with conventional care.
Search strategy
We searched CENTRAL, MEDLINE, Embase, LILACS, CINAHL and trials registries in August 2025. We checked reference lists of included studies, and systematic reviews where subject matter related to the intervention or population examined in this review.
Selection criteria
Randomized controlled trials comparing KMC versus conventional neonatal care, or early-onset KMC versus late-onset KMC, in LBW infants.
Data collection and analysis
Data collection and analysis were performed according to the methods of the Cochrane Neonatal Review Group.
Main results
Twenty-one studies, including 3042 infants, fulfilled inclusion criteria. Nineteen studies evaluated KMC in LBW infants after stabilization, one evaluated KMC in LBW infants before stabilization, and one compared early-onset KMC with late-onset KMC in relatively stable LBW infants. Sixteen studies evaluated intermittent KMC, and five evaluated continuous KMC.
KMC versus conventional neonatal care: At discharge or 40 to 41 weeks' postmenstrual age, KMC was associated with a statistically significant reduction in the risk of mortality (risk ratio [RR] 0.60, 95% confidence interval [CI] 0.39 to 0.92; eight trials, 1736 infants), nosocomial infection/sepsis (RR 0.35, 95% CI 0.22 to 0.54; five trials, 1239 infants), and hypothermia (RR 0.28, 95% CI 0.16 to 0.49; nine trials, 989 infants; moderate-quality evidence). At latest follow-up, KMC was associated with a significantly decreased risk of mortality (RR 0.67, 95% CI 0.48 to 0.95; 12 trials, 2293 infants; moderate-quality evidence) and severe infection/sepsis (RR 0.50, 95% CI 0.36 to 0.69; eight trials, 1463 infants; moderate-quality evidence). Moreover, KMC was found to increase weight gain (mean difference [MD] 4.1 g/d, 95% CI 2.3 to 5.9; 11 trials, 1198 infants; moderate-quality evidence), length gain (MD 0.21 cm/week, 95% CI 0.03 to 0.38; three trials, 377 infants) and head circumference gain (MD 0.14 cm/week, 95% CI 0.06 to 0.22; four trials, 495 infants) at latest follow-up, exclusive breastfeeding at discharge or 40 to 41 weeks' postmenstrual age (RR 1.16, 95% CI 1.07 to 1.25; six studies, 1453 mothers) and at one to three months' follow-up (RR 1.20, 95% CI 1.01 to 1.43; five studies, 600 mothers), any (exclusive or partial) breastfeeding at discharge or at 40 to 41 weeks' postmenstrual age (RR 1.20, 95% CI 1.07 to 1.34; 10 studies, 1696 mothers; moderate-quality evidence) and at one to three months' follow-up (RR 1.17, 95% CI 1.05 to 1.31; nine studies, 1394 mothers; low-quality evidence), and some measures of mother-infant attachment and home environment. No statistically significant differences were found between KMC infants and controls in Griffith quotients for psychomotor development at 12 months’ corrected age (low-quality evidence). Sensitivity analysis suggested that inclusion of studies with high risk of bias did not affect the general direction of findings nor the size of the treatment effect for main outcomes.
Early-onset KMC versus late-onset KMC in relatively stable infants: One trial compared early-onset continuous KMC (within 24 hours post birth) versus late-onset continuous KMC (after 24 hours post birth) in 73 relatively stable LBW infants. Investigators reported no significant differences between the two study groups in mortality, morbidity, severe infection, hypothermia, breastfeeding, and nutritional indicators. Early-onset KMC was associated with a statistically significant reduction in length of hospital stay (MD 0.9 days, 95% CI 0.6 to 1.2).
Authors' conclusions
KMC probably provides clinically important benefits compared with CNC, particularly by reducing mortality and nosocomial infection or sepsis. It may also improve breastfeeding outcomes and reduce hypothermia. Effects on growth and duration of hospitalization remain very uncertain because of substantial heterogeneity and very low-certainty evidence. Evidence for mortality and infection came predominantly from low- and lower-middle-income countries, with limited and imprecise evidence from high-income settings, restricting conclusions about applicability across settings. These conclusions apply to a broad definition of KMC; only a minority of trials evaluated KMC that met the WHO duration criterion, so the pooled results should not be taken as specific estimates of WHO-defined KMC.
Future research should prioritize how KMC can be delivered effectively across health systems, income settings, and infant populations, including contemporary high-income neonatal care settings. Studies should clearly describe intervention components, including whether KMC meets the WHO definition, timing of initiation, daily duration, continuity, setting, provider, and implementation fidelity. Adequately powered trials and implementation studies should use standardized outcome definitions and address outcomes for which evidence remains very uncertain, including growth, hypothermia, and duration of hospitalization. Longer-term follow-up should assess mortality, neurodevelopment, breastfeeding, growth, family-centred outcomes, adverse effects, resource use, cost-effectiveness, equity, and feasibility.
Funding
None.
Registration
Original review (2003): doi.org/10.1002/14651858.CD002771
Last review update (2016): doi.org/10.1002/14651858.CD002771.pub4




